Related references
Note: Only part of the references are listed.Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
Chen Li et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype
Galina Burdyga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders
Kent C. Berridge et al.
BRAIN RESEARCH (2010)
CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
Carmelo Quarta et al.
CELL METABOLISM (2010)
被撤回的出版物: Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells (Retracted article. See vol. 70, pg. 1910, 2021)
Christopher Lipina et al.
DIABETES (2010)
Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
N. Perwitz et al.
DIABETES OBESITY & METABOLISM (2010)
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
K. A. Lindborg et al.
DIABETES OBESITY & METABOLISM (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Bimodal control of stimulated food intake by the endocannabinoid system
Luigi Bellocchio et al.
NATURE NEUROSCIENCE (2010)
Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans
Marica Bordicchia et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
F. J. Bermudez-Silva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
The role of the pancreatic endocannabinoid system in glucose metabolism
Francisco J. Bermudez-Silva et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Leptin Acts via Leptin Receptor-Expressing Lateral Hypothalamic Neurons to Modulate the Mesolimbic Dopamine System and Suppress Feeding
Gina M. Leinninger et al.
CELL METABOLISM (2009)
Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol
Tiziana Bisogno et al.
CHEMMEDCHEM (2009)
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
Vincenzo Di Marzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716)
Aaron N. A. Verty et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation
V. Di Marzo et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
Barbara Batetta et al.
JOURNAL OF NUTRITION (2009)
CB1 antagonists for obesity-what lessons have we learned from rimonabant?
Vincenzo Di Marzo et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure
Aaron N. A. Verty et al.
OBESITY (2009)
Food Intake-independent Effects of CB1 Antagonism on Glucose and Lipid Metabolism
Daniela Cota et al.
OBESITY (2009)
The endocannabinoid system: Role in glucose and energy metabolism
Ruben Nogueiras et al.
PHARMACOLOGICAL RESEARCH (2009)
The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
Vincenzo Di Marzo
PHARMACOLOGICAL RESEARCH (2009)
Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin
Miguel Lopez et al.
CELL METABOLISM (2008)
Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes
Laura Tedesco et al.
DIABETES (2008)
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits Diet-Induced Obese Rats
Ruben Nogueiras et al.
DIABETES (2008)
Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats
Andreas W. Herling et al.
ENDOCRINOLOGY (2008)
Cannabinoids enhance gastric X/A-like cells activity
Robert Lukasz Zbucki et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dysregulation of peripheral endocannabinoid levels in hyperglycernia and obesity: Effect of high fat diets
Isabel Matias et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Genetic variation may influence obesity only under conditions of diet: Analysis of three candidate genes
Jens Aberle et al.
MOLECULAR GENETICS AND METABOLISM (2008)
UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals
Zane B. Andrews et al.
NATURE (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms
Christoph Buettner et al.
NATURE MEDICINE (2008)
End of the line for cannabinoid receptor 1 as an anti-obesity target?
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: Insulin and melanocortins
Isabel Matias et al.
NEUROPHARMACOLOGY (2008)
Neurobiology of Nutrition and Obesity
Christopher D. Morrison et al.
NUTRITION REVIEWS (2008)
The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System
Blerina Kola et al.
PLOS ONE (2008)
Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index
Tes M. Baye et al.
PHARMACOGENOMICS (2008)
Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions
Panayotis K. Thanos et al.
SYNAPSE (2008)
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus
E. Soria-Gomez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endocannabinoid system and gut-brain signalling
Martin A. Storr et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward
Stephen V. Mahler et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Ghrelin, obesity and diabetes
Petra Wiedmer et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate enerpv balance, metabolism, and cardiovascular health
Daniela Cota
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals
G. Murdolo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food
Tiziana Melis et al.
NEUROSCIENCE LETTERS (2007)
Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal
Hao Huang et al.
JOURNAL OF NEUROSCIENCE (2007)
Synaptic regulation of proopiomelanocortin neurons can occur distal to the arcuate nucleus
Shane T. Hentges
JOURNAL OF NEUROPHYSIOLOGY (2007)
The role of CNS fuel sensing in energy and glucose regulation
Daniela Cota et al.
GASTROENTEROLOGY (2007)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
James Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Leptin receptor signaling in midbrain dopamine neurons regulates feeding
Jonathan D. Hommel et al.
NEURON (2006)
Central nervous system control of food intake and body weight
G. J. Morton et al.
NATURE (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues
Bingzhong Xue et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release
Renato Malcher-Lopes et al.
JOURNAL OF NEUROSCIENCE (2006)
Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance
Galina Burdyga et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Involvement of the endocannabinoid system in drug addiction
R Maldonado et al.
TRENDS IN NEUROSCIENCES (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
Attenuated peptide YY release in obese subjects is associated with reduced satiety
CW le Roux et al.
ENDOCRINOLOGY (2006)
Cannabinoids, opioids and eating behavior: The molecular face of hedonism?
Daniela Cota et al.
BRAIN RESEARCH REVIEWS (2006)
Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit
YH Jo et al.
NEURON (2005)
Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward
AE Kelley et al.
PHYSIOLOGY & BEHAVIOR (2005)
Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids
ST Hentges et al.
JOURNAL OF NEUROSCIENCE (2005)
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
KM Gamber et al.
NEUROPHARMACOLOGY (2005)
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
JC Sipe et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Anatomy and regulation of the central melanocortin system
RD Cone
NATURE NEUROSCIENCE (2005)
Gastrointestinal hormones and food intake
AD Strader et al.
GASTROENTEROLOGY (2005)
The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling
S Haj-Dahmane et al.
JOURNAL OF NEUROSCIENCE (2005)
Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin
G Burdyga et al.
JOURNAL OF NEUROSCIENCE (2004)
Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake
ANA Verty et al.
ENDOCRINOLOGY (2004)
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide
PD Cani et al.
BRITISH JOURNAL OF NUTRITION (2004)
The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin
SA Tucci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Hypothalamic orexin neurons regulate arousal according to energy balance in mice
A Yamanaka et al.
NEURON (2003)
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
M Bensaid et al.
MOLECULAR PHARMACOLOGY (2003)
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food?
JA Harrold et al.
BRAIN RESEARCH (2002)
Gut hormone PYY3-36 physiologically inhibits food intake
RL Batterham et al.
NATURE (2002)
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol
TC Kirkham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats
NE Rowland et al.
PSYCHOPHARMACOLOGY (2001)
Anandamide and diet:: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
A Berger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Leptin-regulated endocannabinoids are involved in maintaining food intake
V Di Marzo et al.
NATURE (2001)
Share Paper
